Status:
NOT_YET_RECRUITING
Efficacy, Safety and Neural Mechanism of Stellate Ganglion Block in the Treatment of Anxiety. Disorder.
Lead Sponsor:
Nanjing Medical University
Conditions:
Anxiety Disorders
Stellate Ganglion Block
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
1. In this study, ultrasound-guided Stellate Ganglion Block(SGB) will be used in the treatment of anxiety disorders, combined with relevant scales, HRV indicators and resting state functional magnetic...
Eligibility Criteria
Inclusion
- Aged 18-60 years old
- Diagnosed with various types of anxiety disorders according to the DSM-5, and meet the diagnostic criteria for pain disorders
- Right-handed
- Voluntarily join the study and sign the informed consent.
Exclusion
- Suicidal thoughts and behaviors
- serious physical disease
- diseases of the nervous system or other mental diseases
- Contraindications for MRI examination
- During pregnancy or lactation
- Allergy to narcotic drugs
- Contraindications with stellate ganglion block
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 10 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06540313
Start Date
September 1 2024
End Date
June 10 2026
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Brain Hospital
Nanjing, Jiangsu, China, 210029